Background Low bone mineral density (BMD) value is one of the current concerns in acute lymphoblastic leukemia (ALL) disease are suspected as the predisposing factors for development of osteopenia and osteoporosis. Objectives To obtain the proportion of BMD in children with high risk ALL after Methods We conducted a cross-sectional comparative study from D Results z-score mass index (BMI) and corticosteroid cumulative dose is correlated with the low BMD values in L -L 4 . Conclusion The bone mineral metabolism disorder marked with and osteopenia was observed in ALL patients who underwent chemotherapy. The proportion of the BMD in the two groups were not statistically significant. [Paediatr Indones. 2010;50:365-70].
L eukemia is the most common hematologic malignancy in young children. Owing the survival rate of acute lymphoblastic develop long term side effects from the use of chemotherapeutic drugs and radiotherapy. Current highlighted side effects of intensive chemotherapy are bone mineral density and bone mineral bone mineral density (BMD) increases in childhood and adolescence until peak bone mass is reached in the second or third decade. Failure to achieve peak bone mass during childhood is thought to be a fracture in later life.
The mechanism of osteoporosis in ALL patients including the use of chemotherapeutic agents are suspected as one of the predisposing factors of osteopenia and osteoporosis. Methotrexate (MTX) is a folic acid analog which may cause toxic effects to the bone by the persistent accumulation of MTX-Polyglutamate enzyme. The corticosteroid given simultaneously with MTX also has adverse effects to the bone by increasing osteoclast activity and inhibiting osteoblast activity. 7 Osteoporosis is a condition marked by progressive decrease of bone mass which resulted in the the bone strength to hold its burden and causing is a milder form of bone mass reduction compared to osteoporosis. The categorization of osteopenia and osteoporosis by BMD measurement in children and sex. Osteopenia is defined by z-score between Various studies abroad reported various osteopereported that the incidence of osteopenia in children course of chemotherapy. ALL patients can also develop bone mineral metabolism disorder during the diagnosis of ALL. The disorder is characterized with and osteocalcitonin. chemotherapy in children with ALL have never been conducted in Indonesia. that the aim of this study was D ) in children with ALL in Indonesia.
Methods
We conducted a comparative cross-sectional study admitted to outpatient Hematology-Oncology of chemotherapy maintenance phase. We excluded criteria were selected consecutively until the total consent from parents.
History and physical examination were conduct-with the National Protocol (Jakarta) for high risk ALL. The chemotherapy regiments given during the level using ® kit (electro chemiluminescence immunoassay method).
We measured calcium ion levels with APL ® kit (ion selective electrode method). The mineral density measurement was conducted using ® DEXA (dual x-ray absorptiometry). The available reference value for Results divided into two groups. Group A was children chemotherapy maintenance phase. Distribution medical characteristic is presented in Table 1 and  Table 2 . Table 4) . Table 5 showed a significant negative correlation was observed between BMI and the low BMD L positive correlation between the low BMD L were not proven to correlate with the low BMD L value Discussion who received dexamethasone weree converted to included ALL patients who received prednisone or dexamethasone on their study. The leukocyte count in both groups had a statistically of the correlation of initial leukocyte count with the low BMD z-score in ALL patients has not been understood.
Calcium is a very important mineral to the bone formation process. The hypocalcemia condition in If the amount of vitamin D in thus causing a potential disorder to the vitamin D -D level was caused by increasing cell turnover resulting from chemotherapy. exposure to sunlight and physical activities in ALL patients is another mechanism is expected to play a level. Bone mineral density measurement showed months chemotherapy compared to those in 6 months studied about completing the course of chemotherapy. They found a significant decrease in BMD z-score in lumbal area
We found that body mass index and corticosteroid cumulative dose altered bone density in children who received chemotherapy. Corticosteroid and methotrexate (MTX) is known to have adverse effects to the bone. Although the doses of these two regiments in this study were cause bone formation inhibition. Corticosteroid will hydroxylation needed for the synthesis D calcium absorption will be inhibited. corticosteroid may cause reduction of osteocalcin cytokine which function to inhibit bone resorption.
inhibit the precursor of primitive mesenchyme cells which plays a role in bone mineralization process. the cell will increase the toxicity to bone.
The mechanism between BMI with the low references have proposed a theory about the body's mechanical burden to the bones and adipose tissues as the underlying mechanism of BMD reduction. essential products in the bone mineral metabolism.
bone mineral metabolism disorder. The result of this study found a positive correlation between BMD toxic effects of corticosteroid to the bones can be exerted.
not include healthy children with the same sex and BMD values for healthy Indonesian children were not available. The race difference would did not conduct a detail bone metabolism marker examination because of time and budget limitations. D intake and physical activity assessment were not confounding factors.
and osteopenia was observed in ALL patients who underwent chemotherapy. The proportion of the BMD in the two groups were not statistically significant. 
